Repro-Med Systems Inc. (REPR) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Repro-Med Systems Inc.
Fiscal year is March-February. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 3.77M 4.92M 6.39M 7.76M 8.7M
Cost of Goods Sold (COGS) incl. D&A 1.33M 1.72M 2.36M 3.01M 3.62M
COGS excluding D&A 1.26M 1.66M 2.25M 2.82M 3.39M
Depreciation & Amortization Expense 64,804 65,774 103,981 190,971 232,959
Depreciation 59,258 60,205 98,655 186,521 225,613
Amortization of Intangibles 5,546 5,569 5,326 4,450 7,346
Gross Income 2.45M 3.2M 4.04M 4.75M 5.08M
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 1.73M 2M 2.75M 3.69M 4.07M
Research & Development 27,921 35,519 90,329 147,576 218,150
Other SG&A 1.7M 1.97M 2.66M 3.54M 3.85M
Other Operating Expense 0 0 0 0 0
Unusual Expense 8,609 (28,425) 0 0 0
EBIT after Unusual Expense (8,609) 28,425 0 0 0
Non Operating Income/Expense (4,295) (2,461) 10,718 (4,095) (97)
Non-Operating Interest Income 1,349 8,718 12,848 8,081 7,426
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 47,504 36,392 31,540 28,280 4,547
Gross Interest Expense 47,504 36,392 31,540 28,280 4,547
Interest Capitalized - - - 0 0
Pretax Income 662,460 1.19M 1.28M 1.04M 1.01M
Income Tax (226,984) 489,034 465,291 312,347 307,024
Income Tax - Current Domestic 0 1,691 298,287 229,710 356,024
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic (226,984) 84,210 167,004 82,637 (49,000)
Income Tax - Deferred Foreign 0 403,133 0 - -
Income Tax Credits 0 0 0 0 -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 889,444 704,085 815,893 725,763 703,429
Minority Interest Expense 0 0 0 0 0
Net Income 889,444 704,085 815,893 725,763 703,429
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 889,444 704,085 815,893 725,763 703,429
Preferred Dividends 8,000 0 0 0 0
Net Income Available to Common 881,444 704,085 815,893 725,763 703,429
EPS (Basic) 0.02 0.02 0.02 0.02 0.02
Basic Shares Outstanding 35.38M 36.24M 34.25M 36.01M 36.66M
EPS (Diluted) 0.02 0.02 0.02 0.02 0.02
Diluted Shares Outstanding 38.38M 36.85M 35.1M 36.04M 36.66M
EBITDA 786,323 1.26M 1.39M 1.25M 1.24M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Repro-Med Systems Inc.
Fiscal year is March-February. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 3.77M 4.92M 6.39M 7.76M 8.7M
Cost of Goods Sold (COGS) incl. D&A 1.33M 1.72M 2.36M 3.01M 3.62M
COGS excluding D&A 1.26M 1.66M 2.25M 2.82M 3.39M
Depreciation & Amortization Expense 64,804 65,774 103,981 190,971 232,959
Depreciation 59,258 60,205 98,655 186,521 225,613
Amortization of Intangibles 5,546 5,569 5,326 4,450 7,346
Gross Income 2.45M 3.2M 4.04M 4.75M 5.08M
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 1.73M 2M 2.75M 3.69M 4.07M
Research & Development 27,921 35,519 90,329 147,576 218,150
Other SG&A 1.7M 1.97M 2.66M 3.54M 3.85M
Other Operating Expense 0 0 0 0 0
Unusual Expense 8,609 (28,425) 0 0 0
EBIT after Unusual Expense (8,609) 28,425 0 0 0
Non Operating Income/Expense (4,295) (2,461) 10,718 (4,095) (97)
Non-Operating Interest Income 1,349 8,718 12,848 8,081 7,426
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 47,504 36,392 31,540 28,280 4,547
Gross Interest Expense 47,504 36,392 31,540 28,280 4,547
Interest Capitalized - - - 0 0
Pretax Income 662,460 1.19M 1.28M 1.04M 1.01M
Income Tax (226,984) 489,034 465,291 312,347 307,024
Income Tax - Current Domestic 0 1,691 298,287 229,710 356,024
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic (226,984) 84,210 167,004 82,637 (49,000)
Income Tax - Deferred Foreign 0 403,133 0 - -
Income Tax Credits 0 0 0 0 -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 889,444 704,085 815,893 725,763 703,429
Minority Interest Expense 0 0 0 0 0
Net Income 889,444 704,085 815,893 725,763 703,429
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 889,444 704,085 815,893 725,763 703,429
Preferred Dividends 8,000 0 0 0 0
Net Income Available to Common 881,444 704,085 815,893 725,763 703,429
EPS (Basic) 0.02 0.02 0.02 0.02 0.02
Basic Shares Outstanding 35.38M 36.24M 34.25M 36.01M 36.66M
EPS (Diluted) 0.02 0.02 0.02 0.02 0.02
Diluted Shares Outstanding 38.38M 36.85M 35.1M 36.04M 36.66M
EBITDA 786,323 1.26M 1.39M 1.25M 1.24M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
